Can GLP-1 Medications Reduce Heavy Drinking?

If you want to change your drinking but feel pulled back by cravings, you may wonder whether medication could make that struggle more manageable. You deserve an answer that offers hope without overlooking uncertainty.

Early clinical research suggests that semaglutide, a medication in the GLP-1 family, may reduce heavy drinking and some measures of alcohol craving. GLP-1 receptor agonists are medications used for conditions including diabetes and obesity. They act on brain pathways involved in appetite and reward, which helps explain why researchers are studying their potential relationship with alcohol use. The National Institutes of Health explains the scientific rationale and emerging evidence.

At Avalon Malibu, we approach alcohol addiction treatment as individualized care for the whole person. Medication research belongs within that larger conversation—not as a shortcut around emotional healing, safety, or ongoing support.

What the Research Shows—and What It Does Not

In an eight-week randomized trial of 50 treatment-seeking adults, oral semaglutide reduced heavy-drinking days, drinks per drinking day, and everyday craving compared with placebo. However, the primary laboratory craving measure and overall drinks per day did not show statistically significant differences, making the findings promising but mixed. These results appear in the American Journal of Psychiatry trial.

A separate 26-week randomized trial involving 108 adults with alcohol use disorder and obesity found a greater reduction in heavy-drinking days with injectable semaglutide than with placebo. Both groups received cognitive behavioral therapy, so the study evaluated medication added to psychotherapy—not medication replacing it—and its population limits how broadly the findings can be applied. The trial published in The Lancet supports that distinction.

Our interpretation is cautious: these studies support further investigation, not a conclusion that every GLP-1 medication treats alcohol use disorder. They also do not establish that benefits will continue after medication stops or that medication alone produces lasting recovery.

Understanding Cravings Without Blaming Yourself

Alcohol cravings can involve thoughts, emotions, and physical sensations. They may arise around external cues, such as a familiar drinking environment, or internal experiences, such as tension or frustration. Cravings are also common when people change their drinking, according to NIAAA’s explanation of alcohol urges and triggers.

That complexity matters when interpreting a medication study. Everyday craving and a craving score measured in a laboratory describe related, but not identical, experiences. Improvement in one measure does not necessarily mean improvement in every situation.

We do not treat the presence of a craving as a moral failure. In a treatment conversation, it can be useful information: When did the urge appear? What was happening? How intense did it feel? What happened afterward?

Those details give the conversation more depth than simply asking whether cravings are “better” or “worse.” They also leave room to discuss distress honestly, without turning recovery into a test of willpower.

Research Findings Are Not the Same as Approval

GLP-1 medications are not currently FDA-approved for alcohol use disorder. Promising findings do not automatically establish an approved indication, a standard treatment approach, or suitability for an individual person.

There are already three FDA-approved medications for alcohol use disorder: naltrexone, acamprosate, and disulfiram. They work differently. Naltrexone can reduce the urge to drink; acamprosate helps ease certain symptoms associated with abstinence; and disulfiram causes an unpleasant reaction when alcohol is consumed. NIAAA describes these medications in its overview of established alcohol treatment options.

This information is educational, not a recommendation for any particular medication. A treatment decision requires more than matching a symptom to a drug name. Medical history, other medications, treatment goals, and the ability to monitor benefits and harms all belong in an individualized clinical assessment.

Why Psychotherapy Still Has an Important Role

A reduction in craving would not, by itself, answer every question that recovery raises. What happens during conflict? How does someone handle a stressful evening? What boundaries might support their goals? What happens after a setback?

Behavioral treatments address those practical challenges. Cognitive behavioral therapy, for example, focuses on thoughts, feelings, situations, and behaviors associated with drinking and develops skills for responding differently. Other behavioral approaches address motivation, relationships, and support. NIAAA outlines these functions in its guide to evidence-based alcohol treatment.

In our integrated approach to mental health and addiction care, we coordinate psychiatric evaluation and psychotherapy according to each client’s needs. We also consider co-occurring mental health concerns rather than assuming that a change in drinking resolves every source of distress.

From our perspective, the meaningful question is not whether medication or psychotherapy “wins.” It is how an individualized plan addresses the different needs of the person receiving care.

Safety Matters Beyond the Drinking Outcome

A medication can show a benefit in research and still carry important risks. The current oral semaglutide prescribing information lists common gastrointestinal effects, including nausea, vomiting, and diarrhea, and warnings involving pancreatitis, gallbladder disease, and kidney injury associated with dehydration. It also identifies contraindications involving a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The prescribing information available through DailyMed explains these considerations.

There is a separate safety issue: reducing cravings is not the same as managing alcohol withdrawal. Suddenly stopping after prolonged heavy drinking can cause dangerous withdrawal, including seizures and delirium. NIAAA emphasizes the need for assessment and appropriate medical support in its guidance on alcohol withdrawal and recovery.

If you have been drinking heavily or have experienced withdrawal before, seek medical guidance before making a sudden change. Seizures or severe confusion require emergency medical attention. Research about drinking reduction should never be interpreted as reassurance that unsupported withdrawal is safe.

Questions That Keep the Focus on Your Recovery

You do not need to arrive at a treatment conversation with a preferred medication or a complete plan. It is enough to explain what is happening and what you hope will change.

General questions can help organize that discussion:

• How do my drinking pattern, cravings, and medical history affect the assessment?
• What goals would be clinically appropriate, and how would we measure progress?
• How are the potential benefits and risks of treatment options evaluated?
• How will the plan address emotional distress alongside alcohol use?
• What support will be available if cravings persist or drinking returns?
• How will my care be reviewed and adjusted over time?

You can also describe personal priorities: being present with family, feeling less preoccupied with alcohol, or rebuilding trust. We want to understand what matters to you, not only the number of drinks recorded on a form.

A research finding about fewer heavy-drinking days is not an individualized determination that continued drinking is safe. Goals need to fit the person’s health and circumstances. We can acknowledge change without minimizing remaining concerns, and we can discuss setbacks without treating them as proof that someone cannot recover.

Hope Without a Promise

GLP-1 research offers a reason for cautious hope. It does not offer a universal answer, and you do not need to wait for research to resolve every uncertainty before seeking support.

We believe you deserve care that takes cravings seriously, respects your concerns, and considers your physical and emotional health together. If alcohol use is affecting your life and you would like to learn about support, reach out to us at Avalon Malibu at 888-958-7511. We can begin with a conversation about your needs.